Revelation Biosciences, Inc.
REVB • NASDAQ • Stock Fundamentals
Revelation Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James Rolke, with a market cap of $3.9M.
Market Cap$3.9M
Employees9.0
CEOJames Rolke
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 7, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Revelation Biosciences, Inc. FAQ
Common questions about Revelation Biosciences, Inc.
Revelation Biosciences, Inc. (REVB) has a market capitalization of $3.9M and trades on NASDAQ.
Revelation Biosciences, Inc. has approximately 9 employees.